Exploring Anti-Angiogenic Potential of 1, 3, 4-Oxadiazole Derivatives of Substituted Benzoyl Chloride Via Swissadme Tool

Anti-angiogenic therapy, a traditional strategy in cancer treatment, functions by restricting the formation of new blood vessels, thereby cutting off the supply of oxygen and nutrients to tumor cells. It primarily targets the vascular endothelial growth factor (VEGF) pathway, helping to suppress angiogenesis and improve the outcomes of immunotherapy. The development of novel anti-angiogenic agents is crucial for advancing cancer therapy, and in silico tools have become essential for accelerating the drug discovery process. In this study, ten 1,3,4-oxadiazole derivatives of substituted benzoyl chloride were evaluated for their drug-likeness and pharmacokinetic properties using the Swiss ADME web tool. Key physicochemical descriptors—including molecular weight, topological polar surface area, hydrogen bonding capacity, lipophilicity, and molecular flexibility were assessed alongside drug-likeness filters such as Lipinski, Veber, and Muegge rules. All derivatives demonstrated favorable profiles, with minimal violations, no PAINS alerts, and moderate bioavailability scores (0.55). Despite minor alerts under Brenk and lead-likeness criteria, the compounds exhibited acceptable synthetic accessibility, suggesting good potential for further development. These findings highlight the utility of SwissADME in guiding the early-stage evaluation of drug-like properties, supporting the continued investigation of 1,3,4-oxadiazole scaffolds as promising candidates for anti-angiogenesis therapy.

Anti-angiogenesis, VEGF(Vascular endothelial growth factor), SwissADME, 1,3,4-oxadiazole

1. Kumar, A., D’Souza, S. S., Mysore Nagaraj, S. R., Gaonkar, S. L., Salimath, B. P., & Rai, K. L. (2009). Antiangiogenic and antiproliferative effects of substituted-1, 3, 4-oxadiazole derivatives is mediated by down regulation of VEGF and inhibition of translocation of HIF-1α in Ehrlich ascites tumor cells. Cancer chemotherapy and pharmacology, 64(6), 1221-1233. [Google Scholar] [Crossref]

2. Heriz, M. H., Mahmood, A. A., Yasin, S. R., Saleh, K. M., AlSakhen, M. F., Kanaan, S. I., ... & Tahtamouni, L. H. (2024). Synthesis, docking study, and antitumor evaluation of benzamides and oxadiazole derivatives of 3‐phenoxybenzoic acid as VEGFR‐2 inhibitors. Drug Development Research, 85(3), e22186. [Google Scholar] [Crossref]

3. Heriz, M. H., Mahmood, A. A., Yasin, S. R., Saleh, K. M., AlSakhen, M. F., Kanaan, S. I., ... & Tahtamouni, L. H. (2024). Synthesis, docking study, and antitumor evaluation of benzamides and oxadiazole derivatives of 3‐phenoxybenzoic acid as VEGFR‐2 inhibitors. Drug Development Research, 85(3), e22186. [Google Scholar] [Crossref]

4. Shaker, B., Ahmad, S., Lee, J., Jung, C., & Na, D. (2021). In silico methods and tools for drug discovery. Computers in biology and medicine, 137, 104851. [Google Scholar] [Crossref]

5. Bakchi, B., Krishna, A. D., Sreecharan, E., Ganesh, V. B. J., Niharika, M., Maharshi, S., ... & Shaik, A. B. (2022). An overview on applications of SwissADME web tool in the design and development of anticancer, antitubercular and antimicrobial agents: a medicinal chemist's perspective. Journal of Molecular Structure, 1259, 132712. [Google Scholar] [Crossref]

6. Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific reports, 7(1), 42717. [Google Scholar] [Crossref]

7. El-Sayed, N. N., Almaneai, N. M., Ben Bacha, A., El-Ashrey, M. K., Al-Zaben, M. I., & Almarhoon, Z. M. (2022). Biological evaluation, molecular docking analyses, and ADME profiling of certain new quinazolinones as anti-colorectal agents. ACS omega, 7(22), 18443-18458. [Google Scholar] [Crossref]

8. O'Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011). Open Babel: An open chemical toolbox. Journal of cheminformatics, 3(1), 33. [Google Scholar] [Crossref]

9. Ertl, P., Rohde, B., & Selzer, P. (2000). Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. Journal of medicinal chemistry, 43(20), 3714-3717. [Google Scholar] [Crossref]

10. Gokul, K., Anitha, K. N., Arun Kumar, H. S., Kumbar, V. S., & Chaluvaraju, K. C. (2025). SwissADME-guided drug-likeness evaluation of 1,3,4-oxadiazole Mannich derivatives for Parkinson’s disease. International Journal of Research Publication and Reviews, 6(7), 38–46. [Google Scholar] [Crossref]

11. Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific reports, 7(1), 42717. [Google Scholar] [Crossref]

12. Delaney, J. S. (2004). ESOL: estimating aqueous solubility directly from molecular structure. Journal of chemical information and computer sciences, 44(3), 1000-1005. [Google Scholar] [Crossref]

13. Daina, A., & Zoete, V. (2016). A boiled‐egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem, 11(11), 1117-1121. [Google Scholar] [Crossref]

14. Muegge, I., Heald, S. L., & Brittelli, D. (2001). Simple selection criteria for drug-like chemical matter. Journal of medicinal chemistry, 44(12), 1841-1846. [Google Scholar] [Crossref]

15. Baell, J. B., & Holloway, G. A. (2010). New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. Journal of medicinal chemistry, 53(7), 2719-2740. [Google Scholar] [Crossref]

• Advanced Digital Communication Strategies: A Comprehensive Analysis
• Developing an Explainable AI System for Digital Forensics: Enhancing Trust and Transparency in Flagging Events for Legal Evidence
• The Global Impact of Government Censorship on Women’s Access to Information: A Literature Review
• "Reimagining Higher Education Workspaces: A Review on The Transformative Role of Digital Technology Adoption"
• Improved CSP Efficiency: Innovations and Challenges in Thermal Energy Storage Systems